Needle
ActiveSummary
Needle has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€822,593) and a net result of -€50,313. Equity is shrinking by about 5.2% per year across the filed financial years. The computed 12-month bankruptcy probability is 1.0% (low).
Directors
Board 1
Permanent representatives 1
Statutory auditor 1
Not every act has been read: a resignation may still be missing
Mandate history
- Board
- Statutory auditor
- began earlier
| Name | Functions and periods |
|---|---|
| De Cronos Groep |
|
| KPMG Bedrijfsrevisoren |
|
| Josephus de Wit |
|
| KOO NV |
|
Owners and capital
Owners
1 ownerChain of control
- Nuclys
- De Cronos Groep
- Needle
Highest known parent: Nuclys. The sources do not say who stands above it.
Owners 1
-
100%
According to the 2025 annual accounts of Needle and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Capital and shareholders
- 08-04-2026 Capital increase of €835,000 · to €897,000 · no new shares · in cash
- 08-04-2026 Capital reduction of €835,000 · to €62,000